MECHANICSBURG, Pa., July 31, 2019 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), the parent of Select Medical Corporation, today announced the appointment of Daniel Thomas to its Board of Directors (the "Board"), effective on July 31, 2019.  Mr. Thomas will also serve o

TOLEDO, Ohio, July 31, 2019 /PRNewswire/ -- Welltower Inc. (NYSE: WELL) today announced that is has acquired five purpose-built, private pay seniors housing properties recently developed and managed by Sunrise Senior Living. Welltower previously funded 34% of the development cost for the communities through its joint venture and ownership of Sunrise Senior Living. The fi

TOLEDO, Ohio, July 31, 2019 /PRNewswire/ -- Welltower Inc. (NYSE: WELL) today announced results for the quarter ended June 30, 2019.

TORONTO, July 31, 2019 /PRNewswire/ - Portage Biotech Inc. (PBT.U, OTC Markets: PTGEF) ("Portage" or the "Company") announced today that, further to its news release of July 26, 2019, it will be delayed in filing its audited annual financial statements for the year ended March 31, 2019, the related management's

SOUTH PLAINFIELD, N.J., July 31, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on July 26, 2019 it approved non-statutory stock options to purchase an aggregate of 208,100 shares of its common stock to 72 new employees. The awards were made pursuant to the NASDAQ inducement grant exception as a component of the new hi

BRIDGEWATER, N.J., July 31, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") along with its wholly owned subsidiary, Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases, have agreed to resolve the

VANCOUVER, July 31, 2019 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ("CRH" or the "Company"), today announced its financial and operating results for the three months ended June 30, 2019.Selected Second Quarter 2019 Financial Results (expressed in USD):Second Quarter High

ENGLEWOOD, Colo., July 31, 2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its second quarter ended

WASHINGTON, July 31, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the second quarter ended June 30, 2019."The exceptional commercial performance of HETLIOZ and Fanapt positions Vanda to continue on its path of growth and long term value creation," s

AUSTIN, Texas, July 31, 2019 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced financial results for the second quarter 2019. Financial and operating highlights for the quarter include: Second quarter consolidated revenue increased 4% to $83.1 million from $79.6 million